Vesencumab (Anti-NRP1 / VEGF165R / CD304)

Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.

• Supplier: Selleck Chemicals
• Product #: A2682
• Sku #: A2682-1mg